Met Life Investment Management, LLC Xencor Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Xencor Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 34,852 shares of XNCR stock, worth $720,390. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,852
Previous 34,852 -0.0%
Holding current value
$720,390
Previous $659,000 6.22%
% of portfolio
0.0%
Previous 0.0%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$18.21 - $24.5 $76,263 - $102,606
4,188 Added 13.66%
34,852 $659,000
Q1 2024

May 14, 2024
BUY
$18.65 - $26.52 $571,883 - $813,209
30,664 New
30,664 $678,000
Q2 2023

Apr 29, 2024
BUY
$24.77 - $29.9 $759,547 - $916,853
30,664 New
30,664 $765,000
Q1 2023

May 09, 2024
BUY
$25.95 - $36.95 $795,730 - $1.13 Million
30,664 New
30,664 $855 Million
Q1 2022

May 10, 2024
BUY
$26.68 - $41.63 $818,115 - $1.28 Million
30,664 New
30,664 $818,000
Q1 2022

Mar 22, 2023
BUY
$26.68 - $41.63 $289,584 - $451,852
10,854 Added 54.79%
30,664 $818,000
Q1 2022

May 12, 2022
BUY
$26.68 - $41.63 $289,584 - $451,852
10,854 Added 54.79%
30,664 $818,000
Q4 2021

Jun 21, 2023
SELL
$33.67 - $43.44 $365,454 - $471,497
-10,854 Reduced 35.4%
19,810 $794,000
Q3 2021

May 17, 2024
SELL
$30.65 - $35.68 $79,904 - $93,017
-2,607 Reduced 11.63%
19,810 $646,000
Q3 2021

Jun 21, 2023
SELL
$30.65 - $35.68 $332,675 - $387,270
-10,854 Reduced 35.4%
19,810 $646,000
Q3 2021

Mar 22, 2023
SELL
$30.65 - $35.68 $79,904 - $93,017
-2,607 Reduced 11.63%
19,810 $646,000
Q3 2021

Nov 15, 2021
SELL
$30.65 - $35.68 $79,904 - $93,017
-2,607 Reduced 11.63%
19,810 $647,000
Q2 2021

Jun 21, 2023
SELL
$34.33 - $44.68 $283,119 - $368,475
-8,247 Reduced 26.89%
22,417 $773,000
Q1 2021

May 17, 2024
SELL
$40.81 - $53.88 $336,560 - $444,348
-8,247 Reduced 26.89%
22,417 $965,000
Q1 2021

Jun 26, 2023
SELL
$40.81 - $53.88 $336,560 - $444,348
-8,247 Reduced 26.89%
22,417 $965 Million
Q4 2020

May 24, 2024
SELL
$36.63 - $47.63 $83,955 - $109,167
-2,292 Reduced 9.28%
22,417 $978,000
Q4 2020

Jun 22, 2023
SELL
$36.63 - $47.63 $302,087 - $392,804
-8,247 Reduced 26.89%
22,417 $978,000
Q4 2020

Mar 22, 2023
SELL
$36.63 - $47.63 $83,955 - $109,167
-2,292 Reduced 9.28%
22,417 $978,000
Q4 2020

Feb 16, 2021
SELL
$36.63 - $47.63 $83,955 - $109,167
-2,292 Reduced 9.28%
22,417 $978,000
Q3 2020

Jun 26, 2023
SELL
$30.09 - $43.02 $179,185 - $256,184
-5,955 Reduced 19.42%
24,709 $958,000
Q2 2020

May 24, 2024
SELL
$27.76 - $33.42 $165,310 - $199,016
-5,955 Reduced 19.42%
24,709 $800 Million
Q2 2020

Jun 26, 2023
SELL
$27.76 - $33.42 $165,310 - $199,016
-5,955 Reduced 19.42%
24,709 $800,000
Q2 2020

Mar 22, 2023
BUY
$27.76 - $33.42 $91,302 - $109,918
3,289 Added 15.35%
24,709 $800,000
Q2 2020

Aug 14, 2020
BUY
$27.76 - $33.42 $91,302 - $109,918
3,289 Added 15.35%
24,709 $800,000
Q1 2020

Jul 12, 2023
SELL
$20.69 - $37.79 $191,258 - $349,330
-9,244 Reduced 30.15%
21,420 $640,000
Q4 2019

Jul 12, 2023
SELL
$32.75 - $41.43 $302,741 - $382,978
-9,244 Reduced 30.15%
21,420 $736,000
Q3 2019

Jul 12, 2023
SELL
$33.73 - $46.27 $311,800 - $427,719
-9,244 Reduced 30.15%
21,420 $722,000
Q2 2019

Jul 12, 2023
SELL
$29.6 - $40.93 $273,622 - $378,356
-9,244 Reduced 30.15%
21,420 $876,000
Q1 2019

Jul 13, 2023
SELL
$27.85 - $38.09 $257,445 - $352,103
-9,244 Reduced 30.15%
21,420 $665,000
Q4 2018

Jul 13, 2023
SELL
$32.39 - $42.05 $299,413 - $388,710
-9,244 Reduced 30.15%
21,420 $774,000
Q4 2018

Mar 22, 2023
SELL
$32.39 - $42.05 $382,655 - $496,778
-11,814 Reduced 35.55%
21,420 $774,000
Q4 2018

Feb 14, 2019
SELL
$32.39 - $42.05 $382,655 - $496,778
-11,814 Reduced 35.55%
21,420 $775,000
Q3 2018

Jul 13, 2023
SELL
$35.69 - $47.65 $329,918 - $440,476
-9,244 Reduced 30.15%
21,420 $834,000
Q3 2018

Mar 22, 2023
BUY
$35.69 - $47.65 $91,723 - $122,460
2,570 Added 8.38%
33,234 $1.3 Million
Q3 2018

Nov 14, 2018
BUY
$35.69 - $47.65 $421,641 - $562,937
11,814 Added 55.15%
33,234 $1.3 Million
Q2 2018

Aug 15, 2018
BUY
$28.41 - $42.41 $134,833 - $201,277
4,746 Added 28.46%
21,420 $793,000
Q4 2017

Feb 15, 2018
BUY
$19.29 - $24.83 $321,641 - $414,015
16,674
16,674 $365,000

Others Institutions Holding XNCR

# of Institutions
216
Shares Held
71.5M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.23B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email